Subcellular Localization of Sprouty2 in Human Glioma Cells.
ERK
cytoskeleton
electron microscopy
endosome
super-resolution
vimentin
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
11
2018
accepted:
08
03
2019
entrez:
16
4
2019
pubmed:
16
4
2019
medline:
16
4
2019
Statut:
epublish
Résumé
Sprouty proteins act ubiquitously as signaling integrators and inhibitors of receptor tyrosine kinase (RTK) activated pathways. Among the four Sprouty isoforms, Sprouty2 is a key regulator of growth factor signaling in several neurological disorders. High protein levels correlate with reduced survival of glioma patients. We recently demonstrated that abrogating its function inhibits tumor growth by overstimulation of ERK and induction of DNA replication stress. The important role of Sprouty2 in the proliferation of malignant glioma cells prompted us to investigate its subcellular localization applying super-resolution fluorescence and immunoelectron microscopy. We found that cytoplasmic Sprouty2 is not homogenously distributed but localized to small spots (<100 nm) partly attached to vimentin filaments and co-localized with activated ERK. The protein is associated with early, late and recycling endosomes in response to but also independently of growth factor stimulation. The subcellular localization of Sprouty2 in all areas exhibiting strong RTK activities may reflect a protective response of glioma cells to limit excessive ERK activation and to prevent cellular senescence and apoptosis.
Identifiants
pubmed: 30983969
doi: 10.3389/fnmol.2019.00073
pmc: PMC6449699
doi:
Types de publication
Journal Article
Langues
eng
Pagination
73Références
J Biol Chem. 2000 Oct 20;275(42):32837-45
pubmed: 10887178
J Cell Biol. 2001 Mar 5;152(5):1087-98
pubmed: 11238463
J Biol Chem. 2001 Jun 22;276(25):22742-7
pubmed: 11279012
J Biol Chem. 2002 Feb 1;277(5):3195-201
pubmed: 11698404
Mol Cell Biol. 2002 Nov;22(22):7953-66
pubmed: 12391162
Nat Cell Biol. 2002 Nov;4(11):850-8
pubmed: 12402043
Cell Cycle. 2003 Jul-Aug;2(4):281-2
pubmed: 12851472
Neuron. 2005 Mar 3;45(5):715-26
pubmed: 15748847
Cell Immunol. 2005 Jul-Aug;236(1-2):161-6
pubmed: 16168398
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14058-62
pubmed: 16172380
Trends Cell Biol. 2006 Jan;16(1):45-54
pubmed: 16337795
J Cell Sci. 2005 Dec 15;118(Pt 24):5861-71
pubmed: 16339969
Curr Biol. 2007 Mar 6;17(5):455-61
pubmed: 17320394
J Biol Chem. 2008 Jan 18;283(3):1679-91
pubmed: 17974561
Angiogenesis. 2008;11(1):53-62
pubmed: 18219583
J Endocrinol. 2009 Nov;203(2):191-202
pubmed: 19423641
Mol Pharmacol. 2009 Oct;76(4):679-91
pubmed: 19570949
Mol Cell Neurosci. 2009 Dec;42(4):328-40
pubmed: 19683577
Oncogene. 2010 Sep 23;29(38):5241-53
pubmed: 20661223
Nat Methods. 2013 May;10(5):407-9
pubmed: 23524392
Biochem Biophys Res Commun. 2013 Sep 27;439(3):351-6
pubmed: 24012675
Cancer Metastasis Rev. 2014 Sep;33(2-3):695-720
pubmed: 24744103
Oncotarget. 2016 Sep 13;7(37):59098-59114
pubmed: 27385209
Neuro Oncol. 2018 Jul 5;20(8):1044-1054
pubmed: 29635363
Mol Neurobiol. 2018 Sep 17;:null
pubmed: 30225774
J Cell Biol. 1973 May;57(2):551-65
pubmed: 4121290
Histochem Cell Biol. 1996 Jul;106(1):41-58
pubmed: 8858366